BioCentury | Jun 4, 2019
Politics & Policy

BIO appoints Levin chairman

...Inc. (NASDAQ:GBT) and Welsh is general counsel and president of the North America unit of Royal DSM N.V....
...at Cargill Inc. (Minneapolis, Minn.). Elizabeth S. Eaton, Staff Writer Biotechnology Innovation Organization Global Blood Therapeutics Inc. Ovid Therapeutics Inc. Royal DSM N.V. Hugh...
BioCentury | Jul 13, 2018
Company News

Bain acquires Royal DSM, Sinochem JV

...acquired the DSM Sinochem Pharmaceuticals Ltd. JV of Royal DSM N.V. (Euronext:DSM) and Sinochem Group (Beijing, China). Royal DSM...
...eligible to receive a €50 million ($59 million) earnout. Further financial terms were not disclosed. Royal DSM...
...treatments and beta lactamase (LACTB) inhibitors for LACTB-producing pathogens (see "Royal DSM, Sinochem Group Deal" ). Royal DSM N.V....
BioCentury | May 19, 2017
Financial News

Amyris raises $47M in first tranche of private placement

...raised $47 million in the first tranche of a planned $95 million private placement from Royal DSM...
BioCentury | Apr 18, 2016
Company News

OptiBiotix Health, Royal DSM deal

...OptiBiotix and Royal DSM partnered to develop products to treat microbiome-associated diseases, including diabetes and obesity, using...
...areas where the company already markets its products. Royal DSM’s food-related products include vitamins and nutraceuticals. Royal DSM...
...are not disclosed. Royal DSM did not respond to inquiries. OptiBiotix Health plc (LSE:OPTI), York, U.K. Royal DSM N.V....
BioCentury | Apr 14, 2016
Company News

Management tracks

...oral business. He was global VP of operational excellence at the Patheon Inc. unit of Royal DSM N.V....
BioCentury | Mar 17, 2014
Company News

Patheon, Royal DSM deal

...cash, which the partners said gave the CRO an enterprise value of about $2 billion. Royal DSM...
...and 49% owned by Royal DSM (see BioCentury, Nov. 25, 2013). Patheon Inc. , Durham, N.C. Royal DSM N.V....
BioCentury | Nov 25, 2013
Company News

Patheon, Royal DSM deal

...on Nov. 18, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...
...and Simpson Thacher & Bartlett are legal advisors to JLL. Patheon Inc. (TSX:PTI), Durham, N.C. Royal DSM N.V....
BioCentury | Nov 20, 2013
Company News

DSM, private equity firm taking CRO Patheon private

...Dutch chemicals company Royal DSM N.V. (Euronext:DSM) and private equity firm JLL Partners are teaming up to acquire...
...C$5.94 on Monday, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...
BioCentury | Oct 7, 2013
Company News

Cook Group, JHP Pharmaceuticals, Nanotherapeutics, Royal DSM, U.S. Department of Health and Human Services infectious news

...Research and Development Authority (BARDA) awarded contracts to Cook's Cook Pharmica subsidiary, JHP, Nanotherapeutics and Royal DSM's...
...Inc. , Bloomington, Ind. JHP Pharmaceuticals LLC , Parsippany, N.J. Nanotherapeutics Inc. , Alachua, Fla. Royal DSM N.V....
BioCentury | May 27, 2013
Company News

J&J, Royal DSM deal

...BioCentury, Feb. 12, 2007 & Oct. 11, 2010). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Royal DSM N.V....
Items per page:
1 - 10 of 38
BioCentury | Jun 4, 2019
Politics & Policy

BIO appoints Levin chairman

...Inc. (NASDAQ:GBT) and Welsh is general counsel and president of the North America unit of Royal DSM N.V....
...at Cargill Inc. (Minneapolis, Minn.). Elizabeth S. Eaton, Staff Writer Biotechnology Innovation Organization Global Blood Therapeutics Inc. Ovid Therapeutics Inc. Royal DSM N.V. Hugh...
BioCentury | Jul 13, 2018
Company News

Bain acquires Royal DSM, Sinochem JV

...acquired the DSM Sinochem Pharmaceuticals Ltd. JV of Royal DSM N.V. (Euronext:DSM) and Sinochem Group (Beijing, China). Royal DSM...
...eligible to receive a €50 million ($59 million) earnout. Further financial terms were not disclosed. Royal DSM...
...treatments and beta lactamase (LACTB) inhibitors for LACTB-producing pathogens (see "Royal DSM, Sinochem Group Deal" ). Royal DSM N.V....
BioCentury | May 19, 2017
Financial News

Amyris raises $47M in first tranche of private placement

...raised $47 million in the first tranche of a planned $95 million private placement from Royal DSM...
BioCentury | Apr 18, 2016
Company News

OptiBiotix Health, Royal DSM deal

...OptiBiotix and Royal DSM partnered to develop products to treat microbiome-associated diseases, including diabetes and obesity, using...
...areas where the company already markets its products. Royal DSM’s food-related products include vitamins and nutraceuticals. Royal DSM...
...are not disclosed. Royal DSM did not respond to inquiries. OptiBiotix Health plc (LSE:OPTI), York, U.K. Royal DSM N.V....
BioCentury | Apr 14, 2016
Company News

Management tracks

...oral business. He was global VP of operational excellence at the Patheon Inc. unit of Royal DSM N.V....
BioCentury | Mar 17, 2014
Company News

Patheon, Royal DSM deal

...cash, which the partners said gave the CRO an enterprise value of about $2 billion. Royal DSM...
...and 49% owned by Royal DSM (see BioCentury, Nov. 25, 2013). Patheon Inc. , Durham, N.C. Royal DSM N.V....
BioCentury | Nov 25, 2013
Company News

Patheon, Royal DSM deal

...on Nov. 18, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...
...and Simpson Thacher & Bartlett are legal advisors to JLL. Patheon Inc. (TSX:PTI), Durham, N.C. Royal DSM N.V....
BioCentury | Nov 20, 2013
Company News

DSM, private equity firm taking CRO Patheon private

...Dutch chemicals company Royal DSM N.V. (Euronext:DSM) and private equity firm JLL Partners are teaming up to acquire...
...C$5.94 on Monday, before the deal was announced. The partners plan to combine Patheon with Royal DSM's...
BioCentury | Oct 7, 2013
Company News

Cook Group, JHP Pharmaceuticals, Nanotherapeutics, Royal DSM, U.S. Department of Health and Human Services infectious news

...Research and Development Authority (BARDA) awarded contracts to Cook's Cook Pharmica subsidiary, JHP, Nanotherapeutics and Royal DSM's...
...Inc. , Bloomington, Ind. JHP Pharmaceuticals LLC , Parsippany, N.J. Nanotherapeutics Inc. , Alachua, Fla. Royal DSM N.V....
BioCentury | May 27, 2013
Company News

J&J, Royal DSM deal

...BioCentury, Feb. 12, 2007 & Oct. 11, 2010). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Royal DSM N.V....
Items per page:
1 - 10 of 38